Marshall Wace
FLGT icon

Marshall Wace’s Fulgent Genetics FLGT Stock Holding History

Marshall Wace’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,918
Closed -$269K – 2859
2025
Q1 		$269K Buy
+15,918
New +$271K ﹤0.01% 2304
2024
Q4 		– Sell
-33,777
Closed -$734K – 2713
2024
Q3 		$734K Buy
+33,777
New +$755K ﹤0.01% 1775
2024
Q1 		– Sell
-15,600
Closed -$451K – 2559
2023
Q4 		$451K Buy
15,600
+2,968
+23% +$79.4K ﹤0.01% 1751
2023
Q3 		$338K Buy
12,632
+6,416
+103% +$219K ﹤0.01% 1844
2023
Q2 		$230K Buy
+6,216
New +$217K ﹤0.01% 2213
2023
Q1 		– Sell
-6,900
Closed -$205K – 2809
2022
Q4 		$205K Sell
6,900
-49,109
-88% -$1.76M ﹤0.01% 2698
2022
Q3 		$2.13M Buy
+56,009
New +$2.81M ﹤0.01% 1964
2022
Q1 		– Sell
-10,876
Closed -$1.09M – 3547
2021
Q4 		$1.09M Sell
10,876
-43,610
-80% -$3.83M ﹤0.01% 2437
2021
Q3 		$4.9M Buy
54,486
+47,663
+699% +$4.33M 0.02% 951
2021
Q2 		$629K Sell
6,823
-49,955
-88% -$3.99M ﹤0.01% 2028
2021
Q1 		$5.49M Buy
56,778
+15,756
+38% +$1.63M 0.03% 781
2020
Q4 		$2.14M Buy
+41,022
New +$1.71M 0.01% 923

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Marshall Wace's FLGT Position: Q2 2025 in Review

Marshall Wace sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 15,918 shares — an estimated $269K sold.

Marshall Wace first reported a position in FLGT in Q4 2020 and held it in 12 quarters. The position peaked at $5.49M in Q1 2021. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

  • Marshall Wace reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 15,918 Fulgent Genetics shares in Q2 2025, an estimated $269K.
  • Marshall Wace first reported a position in Fulgent Genetics in Q4 2020 and held it in 12 quarters.
  • Marshall Wace's Fulgent Genetics position peaked at $5.49M in Q1 2021.
  • 167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.